Optimizing RAASi Therapy in Patients with Hyperkalemia: The Role of Potassium Binders - a podcast by ReachMD

from 2021-08-26T00:00

:: ::

CME credits: 0.25

Valid until: 26-08-2022

Claim your CME credit at https://reachmd.com/programs/cme/optimizing-raasi-therapy-patients-hyperkalemia-role-potassium-binders/12767/



It is well understood that RAASi therapy is critical in the management of patients with heart failure. However, hyperkalemia is common in these patients, and its presence often leads to suboptimal RAASi dosing, which in turn results in poorer patient outcomes. Join Drs. Javed Butler and Giuseppe Rosano as they look at a case presentation and discuss the hows and whys of optimal RAASi dosing in patients with heart failure and recurrent hyperkalemia.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD